Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intravenous Senescent Erythrocyte Vaccination Modulates Adaptive Immunity and Splenic Complement Production
Yan He, Chuanxu Cheng, Yuheng Liu, et al.
ACS Nano (2023) Vol. 18, Iss. 1, pp. 470-482
Closed Access | Times Cited: 12

Showing 12 citing articles:

Lymphoid organ-targeted nanomaterials for immunomodulation of cancer, inflammation, and beyond
Jessica C. Hsu, Peng Liu, Yangmeihui Song, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 15, pp. 7657-7680
Closed Access | Times Cited: 11
Multifaceted therapeutic applications of biomimetic nanovaccines
Dev Chheda, Sukhen Shete, Tanisha Tanisha, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 6, pp. 103991-103991
Open Access | Times Cited: 9
Immunogenicity-masking delivery of uricase against hyperuricemia and gout
Zhenglan Ban, Madi Sun, Huihong Ji, et al.
Journal of Controlled Release (2024) Vol. 372, pp. 862-873
Closed Access | Times Cited: 6
Mannan-Decorated Lipid Calcium Phosphate Nanoparticle Vaccine Increased the Antitumor Immune Response by Modulating the Tumor Microenvironment
Liusheng Wu, Lei Yang, Xinye Qian, et al.
Journal of Functional Biomaterials (2024) Vol. 15, Iss. 8, pp. 229-229
Open Access | Times Cited: 5
Biomimetic bioreactor for potentiated uricase replacement therapy in hyperuricemia and gout
Bin Yang, Guihu Luo, Ting Nie, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 12
Open Access
Breaking the barriers in effective and safe toll-like receptor stimulation via nano-immunomodulators for potent cancer immunotherapy
Yaoqi Li, Yitian Chen, Yongan Tang, et al.
Journal of Controlled Release (2025), pp. 113667-113667
Closed Access
Nanovaccine Designed for Splenic Delivery Augments Immune Responses for Tumor Therapy
Xinlong Zang, Zhenghui Jing, Ping Shuai, et al.
(2025)
Closed Access
ROS-neutralizing surface engineering protects immunotoxicity of organic nanoscintillator-directed radiodynamic therapy
Kai Li, Hui Fang, Feixia Ruan, et al.
Chinese Chemical Letters (2025), pp. 111261-111261
Closed Access
Human red blood cells express the RNA sensor TLR7
Lian Lam, Emily Oatman, Kaitlyn Eckart, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Fabrication and functional validation of a hybrid biomimetic nanovaccine (HBNV) against Kit-mutant melanoma
Kishwor Poudel, Zhenyu Ji, Ching-Ni Jenny Njauw, et al.
Bioactive Materials (2024) Vol. 46, pp. 347-364
Closed Access | Times Cited: 1
A Mannose-Modified Lipid Calcium Phosphate Nanoparticle Vaccine Increased the Anti-Tumor Immune Response by Modulating the Tumor Microenvironment
Liusheng Wu, Xinye Qian, Hu Wang, et al.
(2024)
Open Access | Times Cited: 1
Red Blood Cell DNA Capture and Delivery Drives Host Responses During Polymicrobial Sepsis
Long Kwan Lam, Nathan J. Klingensmith, Layal Sayegh, et al.
Research Square (Research Square) (2024)
Open Access
Page 1

Scroll to top